HUP0203097A3 - Phospholipid gel - Google Patents

Phospholipid gel

Info

Publication number
HUP0203097A3
HUP0203097A3 HU0203097A HUP0203097A HUP0203097A3 HU P0203097 A3 HUP0203097 A3 HU P0203097A3 HU 0203097 A HU0203097 A HU 0203097A HU P0203097 A HUP0203097 A HU P0203097A HU P0203097 A3 HUP0203097 A3 HU P0203097A3
Authority
HU
Hungary
Prior art keywords
phospholipid gel
phospholipid
gel
Prior art date
Application number
HU0203097A
Other languages
Hungarian (hu)
Original Assignee
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle Gmbh filed Critical Merckle Gmbh
Publication of HUP0203097A2 publication Critical patent/HUP0203097A2/en
Publication of HUP0203097A3 publication Critical patent/HUP0203097A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1277Processes for preparing; Proliposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/0052Preparation of gels
    • B01J13/0065Preparation of gels containing an organic phase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0203097A 1999-08-25 2000-08-16 Phospholipid gel HUP0203097A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19940227A DE19940227A1 (en) 1999-08-25 1999-08-25 Phospholipid gel
PCT/EP2000/007993 WO2001013887A2 (en) 1999-08-25 2000-08-16 Phospholipin gel

Publications (2)

Publication Number Publication Date
HUP0203097A2 HUP0203097A2 (en) 2003-01-28
HUP0203097A3 true HUP0203097A3 (en) 2006-11-28

Family

ID=7919498

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203097A HUP0203097A3 (en) 1999-08-25 2000-08-16 Phospholipid gel

Country Status (13)

Country Link
EP (1) EP1206245A2 (en)
JP (1) JP2003507408A (en)
AU (1) AU776766B2 (en)
CA (1) CA2381571A1 (en)
CZ (1) CZ2002561A3 (en)
DE (1) DE19940227A1 (en)
HU (1) HUP0203097A3 (en)
NO (1) NO20020768L (en)
PL (1) PL353215A1 (en)
RU (1) RU2261088C2 (en)
SK (1) SK2442002A3 (en)
WO (1) WO2001013887A2 (en)
ZA (1) ZA200201506B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002062316A1 (en) * 2001-02-08 2002-08-15 Vectron Therapeutics Ag Invasomes for the treatment of disease states, production and use thereof
CN1335182A (en) * 2001-08-08 2002-02-13 华中科技大学 Insulin spray for oral cavity and its prepn process
DE10255285A1 (en) * 2002-11-26 2004-06-03 Mcs Micro Carrier Systems Gmbh Self-forming phospholipid gels
DE10255195A1 (en) * 2002-11-27 2004-06-09 Lipoid Gmbh Micellar water-soluble concentrates
ES2301886T3 (en) * 2002-12-20 2008-07-01 Idexx Laboratories, Inc. LIPOSOMAL ANALGESIC FORMULATION INCLUDING DICLOFENAC AND ITS USE FOR HORSE TREATMENT.
US7858115B2 (en) 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
FI20065222L (en) * 2006-04-05 2007-10-06 Finnfeeds Finland Oy Use of inositol
ITMI20081862A1 (en) * 2008-10-21 2010-04-22 Funziona Srl COMPOSITION FOR TOPIC USE FOR THE TREATMENT OF LOCALIZED ADIPOSITIES AND RELATED IMAGINATIONS
EP2711001A3 (en) * 2008-11-14 2014-07-02 Archer-Daniels-Midland Company Organogel compositions and processes for producing
EP2210589B1 (en) * 2009-01-22 2015-05-06 Ludwig-Maximilians-Universität München Vesicular phospholipid gels comprising proteinaceous substances
BE1018506A3 (en) * 2009-02-26 2011-02-01 Bogaert Gina Van COMPOSITION OF A HYDROCORTISONE, ITS DERIVATIVES, METABOLITES, PRODRUGS OR MIXTURES, LIPOSOMAL GEL AND ITS USE.
BR112012029040A2 (en) 2010-05-14 2016-08-02 Archer Daniels Midland Co edible heat-reversible structured phospholipid organogel composition for use in a food product, method of structuring an edible organic phase, food product or ingredient, composition, method of loading an edible heat-reversible structured phospholipid organogel, method of coating a food and edible heat-resistant structured phospholipid for use in a food product
JP2017214299A (en) * 2016-05-30 2017-12-07 ライオン株式会社 Semisolid formulation and method for producing the same
LT3600435T (en) 2017-03-23 2024-04-25 Lipid Systems Sp. Z.O.O. High-efficiency encapsulation of hydrophilic compounds in unilamellar liposomes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0158441B2 (en) * 1984-03-08 2001-04-04 Phares Pharmaceutical Research N.V. Liposome-forming composition
JP2501336B2 (en) * 1987-07-02 1996-05-29 第一製薬株式会社 Stable liposomal formulation
IL94103A0 (en) * 1989-04-25 1991-01-31 Nattermann A & Cie Water-containing formulations with phospholipids,their preparation and application
US5820848A (en) * 1990-01-12 1998-10-13 The Liposome Company, Inc. Methods of preparing interdigitation-fusion liposomes and gels which encapsulate a bioactive agent
DE4003783C2 (en) * 1990-02-08 1999-03-25 Nattermann A & Cie Phospholipid-containing gel, process for its preparation and use
DE4021082C2 (en) * 1990-07-03 1995-08-17 Hans Dr Lautenschlaeger High lipid-containing skin treatment agent using a bilayer-containing system, organic acid salts, alcohol and stabilizer
DE19520659A1 (en) * 1995-06-09 1996-12-12 Mika Pharma Ges Fuer Die Entwi Compsn. to treat virus infections of skin etc
DE19719604A1 (en) * 1997-05-09 1998-07-16 Henkel Kgaa Hair dye, for human hair, that are easier to formulate and apply

Also Published As

Publication number Publication date
EP1206245A2 (en) 2002-05-22
AU776766B2 (en) 2004-09-23
CA2381571A1 (en) 2001-03-01
PL353215A1 (en) 2003-11-03
WO2001013887A3 (en) 2001-09-20
JP2003507408A (en) 2003-02-25
RU2261088C2 (en) 2005-09-27
NO20020768D0 (en) 2002-02-15
NO20020768L (en) 2002-02-15
WO2001013887A2 (en) 2001-03-01
CZ2002561A3 (en) 2002-07-17
SK2442002A3 (en) 2002-08-06
DE19940227A1 (en) 2001-03-08
ZA200201506B (en) 2003-05-28
HUP0203097A2 (en) 2003-01-28
AU7276700A (en) 2001-03-19

Similar Documents

Publication Publication Date Title
HK1200316A1 (en) Therapeutic microfoams
GB2344283B (en) Patient support
AU1101699A (en) Therapeutic pillow
TW501425U (en) Slider-pull-assembling unit
GB9930570D0 (en) Therapy
AUPQ389599A0 (en) Polyelectrolyte gel
HUP0203097A3 (en) Phospholipid gel
GB9907243D0 (en) Therapy
GB9816556D0 (en) Therapy
HK1030332A2 (en) ???
DE60044882D1 (en) Ie
EP1223853A4 (en) Virtual telemicroscope
AU1451600A (en) Human phospholipases
EP1194439A4 (en) Human eag2
AU4456800A (en) Human hac3
AU2227999A (en) Human ependymin
GB2323042B (en) Nebulisers
EP1140120A4 (en) Human brainiac-5
EP1077258A4 (en) Human hrpi
GB9905498D0 (en) Expression
GB2353866B (en) Gel electrophoresis
GB2349986B (en) Potentiometer
GB9916015D0 (en) Gel formation
GB9806039D0 (en) Therapy
TW408625U (en) Assembled block unit

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees